MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Journal of Clinical Oncology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

9,514 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
9,514 works in the cohort · of 4,299,418page 142 of 191

Labels cover 106 of 9,514 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 9,514 of 9,514 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Association between progression-free survival (PFS) rate (PFSR) and overall survival (OS) in LUME-Meso, a study of nintedanib (N) vs. placebo (P) in combination with first-line pemetrexed/cisplatin (PEM/CIS) in patients (pts) with malignant pleural mesothelioma (MPM).
Nick Pavlakis, Federica Grosso, Nicola Steele, Anna K. Nowak, Silvia Novello, Sanjay Popat +13 more
2018· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
The Long and Winding Road
Wendie DenBrok, Christine Simmons, Karen A. Gelmon
2014· letter· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Quality assurance metrics in clinical trial conduct.
Jennifer Li, Susanna Sellmann, Lindsay Philip, Cristina Guglielmi, Pamela Degendorfer, Amit M. Oza
2016· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · metaresearchconsensus · metaresearch
0
citations
affno abstractunlabeled
Reply to L. Wiener et al
Ceilidh J. Eaton Russell, Éric Bouffet
2015· letter· fr· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Pioglitazone and the risk of prostate cancer.
Adi J. Klil‐Drori, Hui Yin, Oriana Hoi Yun Yu, Michaël Pollak, Laurent Azoulay
2016· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Reply to C.D. Atkins
Mark N. Levine, Judith‐Anne W. Chapman, Patti O’Brien, Lois E. Shepherd, Margot J. Burnell
2010· article· en· Journal of Clinical Oncology· Decision Sciences
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Reply to I.H. Sahin
Nirav Thosani, Sonali Thosani, Harminder Singh, Sushovan Guha
2013· letter· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affaboutunlabeled
The McGill Cancer Nutrition and Rehabilitation Program
Martin Chasen, Margaret Eades, Marta Jelowicki, Senda Amdouni, Rahul Sharma
2009· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Clinical outcomes of late relapse in stage I seminoma.
Ali Hosni, Padraig Warde, Philippe L. Bédard, Michael A.S. Jewett, Robert J. Hamilton, Malcolm J. Moore +4 more
2015· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
fundno affno abstractunlabeled
In Reply:
Charles L. Loprinzi
2003· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · insufficient_payloadconsensus · none
0
citations
← previousnext →

How this was built: Screen · Findings · About